These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33801366)

  • 1. Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema.
    Navarro-Partida J; Altamirano-Vallejo JC; Gonzalez-De la Rosa A; Armendariz-Borunda J; Castro-Castaneda CR; Santos A
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33801366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration.
    Navarro-Partida J; Altamirano-Vallejo JC; Aceves Franco LA; Gonzalez-Cortes J; Hernandez-Da Mota S; García-Aguirre JG; Azuara-Galindo CD; Castro-Castaneda CR; Armendariz-Borunda J; Santos A
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.
    Gonzalez-De la Rosa A; Navarro-Partida J; Altamirano-Vallejo JC; Hernandez-Gamez AG; Garcia-Bañuelos JJ; Armendariz-Borunda J; Santos A
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):106-115. PubMed ID: 30614750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
    Cheng T; Li J; Cheng Y; Zhang X; Qu Y
    Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems.
    Aceves-Franco LA; Sanchez-Aguilar OE; Barragan-Arias AR; Ponce-Gallegos MA; Navarro-Partida J; Santos A
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
    Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravitreal triamcinolone acetonide for diffuse diabetic macular edema--one year follow-up].
    Thein R; Pollack A; Bukelman A; Katz H; Pokroy R; Len A; Parnes R; Aloni E; Hauser D
    Harefuah; 2005 Nov; 144(11):759-62, 824. PubMed ID: 16358647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema.
    Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K
    Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observation on treating diabetic macular edema with intravitreal triamcinolone acetonide and laser].
    Wang Y; Shi A; Shi X; Liu W
    Yan Ke Xue Bao; 2010 Aug; 25(1):22-5. PubMed ID: 21166035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early change of central macular thickness after intravitreous triamcinolone or bevacizumab in diabetic macular edema or retinal vein occlusion.
    Sonoda Y; Arimura N; Shimura M; Sakamoto T
    Retina; 2011 Feb; 31(2):290-7. PubMed ID: 21102366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
    Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
    Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
    Koga T; Mawatari Y; Inumaru J; Fukushima M; Tanihara H
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1247-52. PubMed ID: 16021497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone for refractory diabetic macular edema.
    Martidis A; Duker JS; Greenberg PB; Rogers AH; Puliafito CA; Reichel E; Baumal C
    Ophthalmology; 2002 May; 109(5):920-7. PubMed ID: 11986098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
    Kim MW; Moon H; Yang SJ; Joe SG
    Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.